recent activities

ResAd, s.r.o. (LLC) is a company active in the field of research and development in drug epidemiology and policy, providing related consultancy to national and international bodies, and organising educational programs in the field  

recent research and development projects

  • CADAP 6 | Central Asia Drug Programme, component 2 - National Focal Point (NFP) - in partnership for the EC Grant contract with GIZ GmbH; project finished in September 2019. More information on the CADAP6 website.

finalised projects

  • CADAP - DAMOS, phase  5 | Central Asia Drug Action Programme, component Drug Epidemiology Data Base Collection and Development; the CADAP 5 project, realized in 5 countries - Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan -, has been financed by the EuropeAid and conducted by the EU consortium coordinated by German International Cooperation Agency (Deutsche Gesellschaft für Internazionale Zusammenarbeit - giz)

  • systematic review of the literature on the risk of transmission of HIV associated with stimulant use among non-injecting and injecting drug users in Europe (for the European Monitoring Centre for Drugs and Addictions)

  • technical assistance to the National Anti-Drug Committee secretariat in developing the evidence-based drug policy arrangement for strengthening the national drug policy in the Republic of Moldova (for the United Nations Office on Drugs and Crime)

  • study on the problem drug use indicator (for the European Monitoring Centre on Drugs and Drug Addiction)

  • transfer of the Czech best practices in the field of HIV/AIDS prevention to representatives from Tajikistan (for the United Nations Development Programme)

  • Urban Drug Policy in the Globalized World - international conference in cooperation with the Prague Municipal House, and the Global Drug Policy Program of the Open Society Foundations

  • Prague Declaration (on the principles of municipal drug policies)

  • podpořte léčbu konopím  (pro bono support of the petition for legalisation and accessibility of Medical Cannabis in the Czech Republic; Czech only)

  • drug policy advisory to the Czech Ministry of Interior in the period of the Czech Presidency to the European Council, and the coordination of international activities in the field

  • Czech-Ukrainian study tour and scientific cooperation in introduction of drug treatment demand indicator via standardized registers (for the United Nations Development Programme)

  • study on overall mortality of drug users (for the European Monitoring Centre on Drugs and Drug Addiction)

  • transfer of Czech knowledge: strengthening the drug information system in Armenia, and the national drug strategy consultancy (for the United Nations Development Programme)

  • methodology guidance for carrying out a facility survey with the European Facility Survey Questionnaire (EFSQ) - for the European Monitoring Centre for Drugs and Addiction (EMCDDA)

  • assessment of the Methodology of internet web-surveys to collect amounts of drugs used: reliability and validity (for EMCDDA)

  • further analysis on the pilot project ‘European Web Survey on Drugs: patterns of use (for the European Monitoring Centre for Drugs and Addictions)

  • epidemiological research to estimate the number of high risk drug users in Lithuania (for the Vilnius Center for Addictive Disorders)

personal meetings and events

please send a short message via the form bellow or call in advance if interested in personall meeting; for events as consultancy, seminars and conferences, please send invitations to our e-mail

location

ResAd is seated in Prague 8-Karlin, Sokolovska 79/81

(near the subway station Krizikova, yellow B-line)

 Licensed under Creative Commons

follow us
social media
  • Facebook Clean
  • Twitter Clean
  • Google Clean
  • YouTube Clean